Editas Medicine (EDIT) Stock Chart & Stock Price History $2.59 -0.37 (-12.50%) Closing price 07/29/2025 04:00 PM EasternExtended Trading$2.67 +0.08 (+3.24%) As of 07:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine Stock Price Performance The Editas Medicine (EDIT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 52.21%, with a year-to-date return of 103.94%. In the past month, the stock has increased 17.73%, reflecting recent market activity. As of the latest close, Editas Medicine traded at $2.59 with a market cap of $216.81 million and volume of 3.80 million shares. Five years ago, the stock traded at $30.63, representing a 91.54% decrease over that period. At the time, it had a market cap of $1.68 billion and a volume of 459,612 shares. Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-17.78%1 Month Performance+17.73%3 Month Performance+56.97%Year-To-Date Performance+103.94%1 Year Performance-52.21%5 Year Performance-91.54% EDIT Stock Chart for Wednesday, July, 30, 2025 EDIT Chart by TradingView Editas Medicine Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/29/2025$2.96$2.59-12.50%$2.99$2.553.80 million shs$216.81 million07/28/2025$3.15$2.96-6.03%$3.19$2.941.80 million shs$247.79 million07/25/2025$3.26$3.15-3.37%$3.28$3.101.27 million shs$263.70 million07/24/2025$3.46$3.26-5.78%$3.58$3.182.66 million shs$272.90 million07/23/2025$3.36$3.46+2.98%$3.54$3.282.46 million shs$289.64 million07/22/2025$3.15$3.36+6.67%$3.42$3.032.60 million shs$281.28 million07/21/2025$2.76$3.15+14.13%$3.39$2.795.76 million shs$263.69 million07/18/2025$2.73$2.76+1.10%$2.87$2.662.54 million shs$231.04 million07/17/2025$2.84$2.73-3.87%$2.89$2.701.83 million shs$228.53 million07/16/2025$2.75$2.84+3.27%$3.02$2.702.56 million shs$237.75 million Get the Latest News and Ratings for EDIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. 07/15/2025$2.85$2.75-3.51%$2.96$2.731.55 million shs$230.20 million07/14/2025$2.88$2.85-1.04%$2.96$2.741.27 million shs$238.57 million07/11/2025$3.06$2.88-5.88%$3.09$2.802.25 million shs$241.09 million07/10/2025$3.08$3.06-0.65%$3.18$2.992.56 million shs$256.15 million07/09/2025$2.86$3.08+7.69%$3.24$2.925.59 million shs$257.84 million07/08/2025$2.54$2.86+12.60%$3.07$2.545.70 million shs$239.41 million07/07/2025$2.59$2.54-1.74%$2.63$2.482.14 million shs$212.62 million07/04/2025$2.59$2.59$2.75$2.511.91 million shs$216.39 million07/03/2025$2.56$2.59+0.98%$2.75$2.511.91 million shs$216.39 million07/02/2025$2.25$2.56+13.78%$2.88$2.239.52 million shs$214.30 million07/01/2025$2.20$2.25+2.27%$2.31$2.111.75 million shs$188.35 million06/30/2025$2.28$2.20-3.51%$2.37$2.192.24 million shs$184.17 million Related Companies Beam Therapeutics Stock Chart CRISPR Therapeutics Stock Chart Intellia Therapeutics Stock Chart Sana Biotechnology Stock Chart Avadel Pharmaceuticals Stock Chart Ardelyx Stock Chart Enliven Therapeutics Stock Chart Dyne Therapeutics Stock Chart Iovance Biotherapeutics Stock Chart Structure Therapeutics Stock Chart Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EDIT) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EDIT Stock Alerts